 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
May 15, 2012
Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - SQI Diagnostics Abandons Bid to Acquire Scienion, Withdraws IPO
October 11, 2011 / BioArray News - SQI Diagnostics Amends Purchase Deal of Scienion to Push Back Termination Date
September 27, 2011 / GenomeWeb Daily News - SQI Buying Microarray Firm Scienion for $15.6M, and Stock
July 5, 2011 / GenomeWeb Daily News - CombiMatrix Shares up Sharply as Firm Reports Record Prenatal Testing Volumes in Preliminary Q1 Results
April 4, 2013 / GenomeWeb Daily News